Corrigendum: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson's disease

Rui Wang,Shanshan Tong,Mengdi Wang,Junjie Zou,Nan Wang,Fengjiao Sun,Xiaosheng Zhou,Jinbo Chen,Hongcai Wang

DOI: https://doi.org/10.3389/fnagi.2023.1250440

2023-08-02

Abstract:[This corrects the article DOI: 10.3389/fnagi.2023.1122647.].

What problem does this paper attempt to address?

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].
Corrigendum: Uncovering the Pharmacology of Ginkgo Biloba Folium in the Cell-Type-specific Targets of Parkinson’s Disease with a Deep Learning Algorithm

Yu-Chen Yan,Zhi-Heng Xu,Jian Wang,Wen-Bo Yu

DOI: https://doi.org/10.3389/fphar.2022.1115043

IF: 5.6

2023-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1007556.].
Corrigendum to “Ginsenoside Rb1 attenuates methamphetamine (METH)-induced neurotoxicity through the NR2B/ERK/CREB/BDNF signalings in vitro and in vivo models” [J Ginseng Res 46 (2022) 426-434]

Genmeng Yang,Juan Li,Yanxia Peng,Baoyu Shen,Yuanyuan Li,Liu Liu,Chan Wang,Yue Xu,Shucheng Lin,Shuwei Zhang,Yi Tan,Huijie Zhang,Xiaofeng Zeng,Qi Li,Gang Lu

DOI: https://doi.org/10.1016/j.jgr.2023.01.001

IF: 5.735

2023-03-01

Journal of Ginseng Research

Abstract:[This corrects the article DOI: 10.1016/j.jgr.2021.07.005.].

chemistry, medicinal,integrative & complementary medicine
Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Xiu-Ying He,Yang Xu,Qing-Jie Xia,Xiao-Ming Zhao,Shan Li,Xiao-Qiong He,Ru-Rong Wang,Ting-Hua Wang

DOI: https://doi.org/10.3389/fonc.2022.872110

IF: 4.7

2022-03-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.663262.].

oncology
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Yang Han,Chunhong Gao,Hao Wang,Jiejie Sun,Meng Liang,Ye Feng,Qianqian Liu,Shiyao Fu,Lin Cui,Chunsheng Gao,Yi Li,Yang Yang,Baoshan Sun

DOI: https://doi.org/10.1016/j.bioactmat.2021.06.002

IF: 18.9

2022-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2020.08.017.].

engineering, biomedical,materials science, biomaterials
Corrigendum: Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression

Huiqin Wang,Yantao Yang,Songwei Yang,Siyu Ren,Juling Feng,Yangbo Liu,Haodong Chen,Naihong Chen

DOI: https://doi.org/10.3389/fphar.2024.1418824

2024-07-17

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.709019.].
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Corrigendum: Müller Cell Regulated Microglial Activation and Migration in Rats With N-Methyl-N-Nitrosourea-Induced Retinal Degeneration

Shuai Zhang,Shanshan Zhang,Wenqing Gong,Guopei Zhu,Songtao Wang,Yalin Wang,Michael Halim,Kaidi Wang,Guomin Zhou,Qiong Liu

DOI: https://doi.org/10.3389/fnins.2020.606486

IF: 4.3

2020-10-22

Frontiers in Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnins.2018.00890.].

neurosciences
Corrigendum to 'CRISPR/Cas9 system and its applications in nervous system diseases' [Genes & Diseases 11 (2024) 675-686]

Haibin Jiang,Mengyan Tang,Zidi Xu,Yanan Wang,Mopu Li,Shuyin Zheng,Jianghu Zhu,Zhenlang Lin,Min Zhang

DOI: https://doi.org/10.1016/j.gendis.2024.101392

2024-08-19

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2023.03.017.].
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu-Sheng Liu,Lu-Meng Zhou,Ling-Ling Yuan,Yan Gao,Xue-Yan Kui,Xiao-Yu Liu,Zhi-Jun Pei

DOI: https://doi.org/10.3389/fimmu.2021.751004

IF: 7.3

2021-08-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.724741.].

immunology
Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer

Xing Bian,Xiaolin Wang,Qiuyan Zhang,Liying Ma,Guozhen Cao,Ao Xu,Jinhua Han,Jun Huang,Wenchu Lin

DOI: https://doi.org/10.3389/fonc.2023.1192526

IF: 4.7

2023-04-13

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.565820.].

oncology
Corrigendum: Characteristics and influencing factors of 11C-CFT PET imaging in patients with early and late onset Parkinson's disease

Fan Kangli,Zhao Hongguang,Li Yinghua,Du Xiaoxiao,Dai Yuyin,Gao Lulu,Li Yi,Sun Zhihui,Zhang Ying

DOI: https://doi.org/10.3389/fneur.2023.1289550

IF: 3.4

2023-09-21

Frontiers in Neurology

Abstract:[This corrects the article DOI: 10.3389/fneur.2023.1195577.].

neurosciences,clinical neurology
Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy: Erratum

Meng-Lu Chen,Chun-Gu Hong,Tao Yue,Hong-Ming Li,Ran Duan,Wen-Bao Hu,Jia Cao,Zhen-Xing Wang,Chun-Yuan Chen,Xiong-Ke Hu,Ben Wu,Hao-Ming Liu,Yi-Juan Tan,Jiang-Hua Liu,Zhong-Wei Luo,Yan Zhang,Shan-Shan Rao,Ming-Jie Luo,Hao Yin,Yi-Yi Wang,Kun Xia,Si-Yuan Tang,Hui Xie,Zheng-Zhao Liu

DOI: https://doi.org/10.7150/thno.67227

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.47408.].

medicine, research & experimental
Corrigendum: MicroRNA339 Targeting PDXK Improves Motor Dysfunction and Promotes Neurite Growth in the Remote Cortex Subjected to Spinal Cord Transection

Liu-Lin Xiong,Yan-Xia Qin,Qiu-Xia Xiao,Yuan Jin,Mohammed Al-Hawwas,Zheng Ma,You-Cui Wang,Visar Belegu,Xin-Fu Zhou,Lu-Lu Xue,Ruo-Lan Du,Jia Liu,Xue Bai,Ting-Hua Wang

DOI: https://doi.org/10.3389/fcell.2022.877291

IF: 5.5

2022-04-13

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.00577.].

cell biology,developmental biology
Corrigendum: Association Between Metabolic Syndrome and Mild Parkinsonian Signs Progression in the Elderly

Zeyan Peng,Rui Zhou,Dong Liu,Min Cui,Ke Yu,Hai Yang,Ling Li,Juan Liu,Yang Chen,Wenjuan Hong,Jie Huang,Congguo Wang,Jingjing Ma,Huadong Zhou

DOI: https://doi.org/10.3389/fnagi.2021.790099

IF: 4.8

2021-11-24

Frontiers in Aging Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnagi.2021.722836.].

neurosciences,geriatrics & gerontology,gerontology
Corrigendum To: NGF Protects Neuroblastoma Cells Against Β‐amyloid Induced Apoptosis Via the Nrf2/HO‐1 Pathway

Rui Su,Wei Su,Qian Jiang

DOI: https://doi.org/10.1002/2211-5463.12782

2020-01-01

FEBS Open Bio

Abstract:[This corrects the article DOI: 10.1002/2211-5463.12742.].
Author Correction: A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology

Jinhong Wie,Zhenjiang Liu,Haikun Song,Thomas F. Tropea,Lu Yang,Huanhuan Wang,Yuling Liang,Chunlei Cang,Kimberly Aranda,Joey Lohmann,Jing Yang,Boxun Lu,Alice S. Chen-Plotkin,Kelvin C. Luk,Dejian Ren

DOI: https://doi.org/10.1038/s41586-021-03438-x

IF: 64.8

2021-03-31

Nature

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41586-021-03438-x.

multidisciplinary sciences
Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Wan Li,Liwen Ren,Xiangjin Zheng,Jinyi Liu,Jinhua Wang,Tengfei Ji,Guanhua Du

DOI: https://doi.org/10.1016/j.apsb.2024.04.025

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2019.12.012.].
Corrigendum: Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer's Disease

Chen Chen,Yao Chen,Zhong-Hao Zhang,Shi-Zheng Jia,Yu-Bin Chen,Shao-Ling Huang,Xin-Wen Xu,Guo-Li Song

DOI: https://doi.org/10.3389/fnagi.2021.815251

IF: 4.8

2021-12-20

Frontiers in Aging Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnagi.2021.750921.].

neurosciences,geriatrics & gerontology,gerontology

Corrigendum: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson's disease

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum: Uncovering the Pharmacology of Ginkgo Biloba Folium in the Cell-Type-specific Targets of Parkinson’s Disease with a Deep Learning Algorithm

Corrigendum to “Ginsenoside Rb1 attenuates methamphetamine (METH)-induced neurotoxicity through the NR2B/ERK/CREB/BDNF signalings in vitro and in vivo models” [J Ginseng Res 46 (2022) 426-434]

Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Corrigendum: Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Corrigendum: Müller Cell Regulated Microglial Activation and Migration in Rats With N-Methyl-N-Nitrosourea-Induced Retinal Degeneration

Corrigendum to 'CRISPR/Cas9 system and its applications in nervous system diseases' [Genes & Diseases 11 (2024) 675-686]

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer

Corrigendum: Characteristics and influencing factors of 11C-CFT PET imaging in patients with early and late onset Parkinson's disease

Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy: Erratum

Corrigendum: MicroRNA339 Targeting PDXK Improves Motor Dysfunction and Promotes Neurite Growth in the Remote Cortex Subjected to Spinal Cord Transection

Corrigendum: Association Between Metabolic Syndrome and Mild Parkinsonian Signs Progression in the Elderly

Corrigendum To: NGF Protects Neuroblastoma Cells Against Β‐amyloid Induced Apoptosis Via the Nrf2/HO‐1 Pathway

Author Correction: A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Corrigendum: Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer's Disease